Aristotle University Of Thessaloniki (AUTH)
Ο προσδιορισμός των μεταλλοπρωτεϊνασών και των φυσικών αναστολέων τους κατά τη διάρκεια εγχειρήσεων αορτοστεφανιαίας παράκαμψης με και χωρίς εξωσωματική κυκλοφορία
Abstract
dc:descriptionBACKROUND: The use of the Cardiopulmonary Bypass (CPB) during coronary bypass surgery may be responsible for a series of potentially dangerous consequences with which the Systemic Inflammatory Response Syndrome (SIRS) and the Ischemia-Reperfusion Injury are associated. The development of SIRS and Ischemia-Reperfusion injury during CPB have been found to be associated with the activation of Matrix Metalloproteinases (MMPs). Coronary surgery without CPB is based on the argument that, eliminating CPB significantly, decreases the secretion of proinflammatory substances that stimulate the SIRS syndrome, and reduces the duration of ischemia which is responsible for Ischemia-Reperfusion injury.The purpose of this prospective, randomized study was the identification of metalloproteinases MMP-9 and MMP-13 in patients undergoing CABG with and without CPB and the study of concurrent changes of TIMP-1 and TIMP-4.METHODS: The current prospective, randomized study included 40 patients who underwent elective coronary bypass. The inclusion and exclusion criteria of the study were determined based on a thorough literature review. During their entrance in the study, the patients were randomized into two groups, and post-randomization analysis of the two groups showed they have similar demographic characteristics. Group A patients (CCABG) underwent coronary bypass under CPB, while Group B patients (OPCAB) underwent off-pump coronary bypass without CPB. Blood was drawn from the central venous catheter of all patients, in order to measure plasma levels of MMP-9, MMP-13, TIMP-1 and TIMP-4 at four specific timepoints during the surgery. RESULTS: There was no association between the pre-operative levels of MMP-9/MMP-13/TIMP-1/TIMP-4 and the surgical risk (as estimated byEuroSCORE) or the severity of the coronary artery disease (as estimatedby the number of grafts needed). Analysis of the levels of MMP-9 and TIMPs between the two groups at various timepoints showed that during CPB (CCABG) in coronary bypass surgery – which is associated with trauma due to blood contact with the CPB-circuit tubing and also Ischemia-Reperfusion injury after aortic clamp release – there is an increase of the plasma levels of MMP-9, with consequent decrease of the plasma levels of TIMP-1. These changes become evident immediately before the disconnection of the patient from the CPB circuit. After the disconnection of the patient from the CPB circuit and until the end of the operation, the MMP-9 activation ceases and its plasma level drops, but this is not associated with its endogenous suppression by TIMPs. On the other hand, in coronary bypass surgery without CPB (OPCAB) – which is associated with intermittent periods of local ischemia secondary to surgical manipulations for the performing of the peripheral anastomoses – there is no activation of MMP-9. During the subsequent reperfusion phase, there is also no activation of MMP-9.Analysis of the levels of MMP-13 shows that they do not exhibit any statistically significant change between the two groups at any of the timepoints, and there are no associated changes in TIMPs levels.CONCLUSION: In conclusion, CCABG operations involve the production and activation of MMP-9 for a significant duration of time. The association of increased MMP-9 expression with high morbidity, organ dysfunction and clinical syndromes in CCABG operations necessitates further studies.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Rouska, Efthymia
- Ρούσκα, Ευθυμία
Subjects
dc:subject × 14- Μεταλλοπρωτεϊνάσες
- Φυσικοί αναστολείς μεταλλοπρωτεϊνασών
- Αορτοστεφανιαία παράκαμψη με εξωσωματική κυκλοφορία
- Αορτοστεφανιαία παράκαμψη χωρίς εξωσωματική κυκλοφορία
- Matrix metalloproteinases
- Tissue inhibitors of metalloproteinases
- Coronary artery bypass with cardiopulmonary bypass
- Coronary artery bypass grafting without cardiopulmonary bypass
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Κλινική Ιατρική
- Medical and Health Sciences
- Basic Medicine
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36952